Patient persistence with first-line antiglaucomatous monotherapy.

Patient persistence with first-line antiglaucomatous monotherapy.

Item
http://www.wikidata.org/entity/Q33819822
Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusObjective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic reviewPreservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension.In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis).Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma.Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction.Latanoprost in the treatment of glaucoma.Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions.
P2860

Patient persistence with first-line antiglaucomatous monotherapy.

Item
http://www.wikidata.org/entity/Q33819822
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Patient persistence with first-line antiglaucomatous monotherapy.
@ast
Patient persistence with first-line antiglaucomatous monotherapy.
@en
type
label
Patient persistence with first-line antiglaucomatous monotherapy.
@ast
Patient persistence with first-line antiglaucomatous monotherapy.
@en
prefLabel
Patient persistence with first-line antiglaucomatous monotherapy.
@ast
Patient persistence with first-line antiglaucomatous monotherapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P932
P356
P1433
P1476
Patient persistence with first-line antiglaucomatous monotherapy
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P932